{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-017402","form_type":"8-K","ticker":"IRIX","cik":"0001006045","company_name":"IRIDEX CORP","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.560073+00:00","generated_at":"2026-06-23T23:40:32.473459+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Iridex Q2 revenue $13.8M (+2% YoY); net loss $2.2M; lowers FY22 guidance","bullets":["Total revenue $13.8M, up 2% YoY; net loss $2.2M ($0.14/sh) vs net income $1.4M ($0.09) prior year due to one-time PPP loan forgiveness.","Gross margin 45.6% vs 45.5% YoY; operating expenses rose 16% to $8.4M on sales/marketing and R&D investment.","Cyclo G6 probe sales of 15,000 (-6% YoY); full-year probe guidance cut to 61k-63k from prior 67k-70k.","Revenue guidance lowered to $56M-58M from $57M-59M, reflecting 4%-8% growth; management cites macro headwinds and COVID surge.","Received NMPA clearance to market Cyclo G6 platform in China; sold initial systems and conducted clinical launch with 70 physicians."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-017402","json":"https://secwatch.observer/filing/0000950170-22-017402.json","markdown":"https://secwatch.observer/filing/0000950170-22-017402.md","text":"https://secwatch.observer/filing/0000950170-22-017402.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006045/000095017022017402/0000950170-22-017402-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006045/000095017022017402/irix-20220815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:40:32.473459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}